Showing 13 of 13 recruiting trials for “igg4-related-ophthalmic-disease”
Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease
A Study of Efgartigimod in Patients With IgG4-Related Disease
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
👨⚕️ JIAN ZHU, M.D./Ph.D., Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital, Beijing📍 1 site📅 Started Sep 2025View details ↗
A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease
A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD
Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
Short-term Glucocorticoid Combined with MMF for IgG4-RD
Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement
Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement
RecruitingNCT03023371 ↗
National Registry of IgG4-RD in China
RecruitingNCT01670695 ↗
A Prospective Cohort Study of IgG4RD in China
👨⚕️ Wen Zhang, MD, Deptment of Rheumatology, Peking Union Medical College Hospital📍 1 site📅 Started Jan 2012View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →